Ammonia Solution, Strong

Ammonia Solution, Strong

SCHEMBL410567

C1CCC(CC2CCCCC2)CC1.N.N

nearest known ligand 0.50

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM5 P08912 2/20 0.41
CYP1A2 P05177 1/20 0.41
ADRA2C P18825 1/20 0.41
CHRM2 P08172 1/20 0.41
CHRM4 P08173 1/20 0.41
CHRM1 P11229 1/20 0.41
NOS1 P29475 1/20 0.41
NOS2 P35228 1/20 0.41
SIGMAR1 Q99720 2/20 0.38
ADH1B P00325 1/20 0.38
ADH1C P00326 1/20 0.38
ADH1A P07327 1/20 0.38
ADH4 P08319 1/20 0.38
ADH7 P40394 1/20 0.38
MEN1 O00255 1/20 0.35
MAPT P10636 1/20 0.35
KMT2A Q03164 1/20 0.35
ATM Q13315 1/20 0.35
ACHE P22303 1/20 0.35
EPHX1 P07099 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ammonia Solution, Strong SCHEMBL26667039 1.00 CHRM5 (0.41) CHRM5CYP1A2ADRA2CCHRM2CHRM4
Ammonia Solution, Strong SCHEMBL9555998 0.96 NOS1 (0.39) CHRM5CYP1A2ADRA2CCHRM2CHRM4
SCHEMBL3224864 0.96 CHRM5 (0.43) CHRM5CYP1A2ADRA2CCHRM2CHRM4
SCHEMBL3222970 0.96 CHRM5 (0.43) CHRM5CYP1A2ADRA2CCHRM2CHRM4
SCHEMBL2904004 0.96 CHRM5 (0.43) CHRM5CYP1A2ADRA2CCHRM2CHRM4
SCHEMBL23070439 0.96 CHRM5 (0.43) CHRM5CYP1A2ADRA2CCHRM2CHRM4
SCHEMBL187659 0.96 CHRM5 (0.43) CHRM5CYP1A2ADRA2CCHRM2CHRM4
SCHEMBL1930290 0.96 CHRM5 (0.43) CHRM5CYP1A2ADRA2CCHRM2CHRM4
SCHEMBL1524658 0.96 CHRM5 (0.43) CHRM5CYP1A2ADRA2CCHRM2CHRM4
SCHEMBL6532715 0.96 CHRM5 (0.43) CHRM5CYP1A2ADRA2CCHRM2CHRM4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 368 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119331177-B Modified polyurethane dispersoid and preparation method thereof 万华化学集团股份有限公司 2026-05-19 CN claimed
CN-122060388-A Bio-based aqueous single-component polyurethane waterproof coating and preparation method thereof 万华化学集团股份有限公司 2026-05-19 CN claimed
CN-119490638-A Aqueous polyurethane dispersion liquid and preparation method thereof 汕头市鑫源化工科技有限公司 2025-02-21 CN claimed
US-20250051268-A1 METHOD FOR PREPARING ISOCYANATE BY MEANS OF GAS-PHASE SOLVENT-FREE METHOD MOJIA (SHANGHAI) BIOTECH CO., LTD. (CN) 2025-02-13 US claimed
CN-119331177-A Modified polyurethane dispersoid and preparation method thereof 万华化学集团股份有限公司 2025-01-21 CN claimed
CN-119264984-A Reticular double-shell essence microcapsule and preparation method thereof 湖北兴瑞硅材料有限公司 2025-01-07 CN claimed
CN-119264359-A Polyurethane ink resin and preparation method and application thereof 万华化学(北京)有限公司 2025-01-07 CN claimed
US-12180136-B2 Organic amine collection method ASAHI KASEL KABUSHIKI KAISHA (JP) 2024-12-31 US claimed
CN-119081609-A Recoverable mussel-like bio-based epoxy resin adhesive and preparation method thereof 西南大学 2024-12-06 CN claimed
CN-118955834-A Epoxy vegetable oil glass polymer material and preparation method thereof 西南大学 2024-11-15 CN claimed
US-9029010-B2 Molding packaging material and molded case SHOWA DENKO PACKAGING CO., LTD. (JP) 2015-05-12 US claimed
US-20130244088-A1 MOLDING PACKAGING MATERIAL AND MOLDED CASE SHOWA DENKO PACKAGING CO., LTD. (JP) 2013-09-19 US claimed
US-6683152-B2 PREPOLYMER COMPRISED OF POLYOL AND POLYISOCYANATE, AND CURING AGENT; DURABILITY, RESILIENCE ACUSHNET COMPANY 2004-01-27 US claimed
EP-0705287-B1 POLYUREAURETHANE PRIMERLESS STRUCTURAL ADHESIVE ASHLAND OIL INC (US) 2002-10-16 EP claimed
US-20020004429-A1 Polyurethane golf club inserts JPMORGAN CHASE BANK, N.A., AS SUCCESSOR ADMINISTRATIVE AGENT 2002-01-10 US claimed
US-6210294-B1 A CENTER, A COVER, AND INTERMEDIATE LAYERS, AND AT LEAST ONE OF THESE IS A POLYURETHANE, MADE FROM A POLYISOCYANATE, A POLYOL, AND A DIOL CURING AGENT ACUSHNET COMPANY 2001-04-03 US claimed
WO-2000069527-A1 POLYURETHANE GOLF BALL WITH IMPROVED RESILIENCY ACUSHNET COMPANY (US) 2000-11-23 WO claimed
US-5753749-A Dicyclohexylmethane diisocyanate residue-based compositions and the use of such compositions as fillers BAYER CORPORATION (US) 1998-05-19 US claimed
US-5548056-A FOR FIBERGLASS REINFORCED POLYESTER ASHLAND INC. (US) 1996-08-20 US claimed
EP-0100029-B1 COATED COMPOUND MATERIAL, PROCESS FOR ITS PRODUCTION AND ITS USE IN THE LINING OF OUTLETS BAYER AG (DE) 1986-09-10 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12180136-B2 Organic amine collection method H1-0, F12, C1S CHRM5 215/4885CYP1A2 957/4885ADRA2C 1643/4885
US-20250051268-A1 METHOD FOR PREPARING ISOCYANATE BY MEANS OF GAS-PHASE SOLVENT-FREE METHOD TST, GRHPR, IDH2 CHRM5 3372/4885CYP1A2 309/4885ADRA2C 4398/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.